Universal Beteiligungs und Servicegesellschaft mbH Decreases Stock Position in Rxo Inc $RXO

Universal Beteiligungs und Servicegesellschaft mbH decreased its position in shares of Rxo Inc (NYSE:RXOFree Report) by 90.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,799 shares of the company’s stock after selling 97,791 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in RXO were worth $170,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. CWM LLC boosted its position in RXO by 234.4% in the 1st quarter. CWM LLC now owns 1,876 shares of the company’s stock valued at $36,000 after buying an additional 1,315 shares during the last quarter. TD Asset Management Inc purchased a new position in RXO in the first quarter valued at about $1,907,000. PNC Financial Services Group Inc. boosted its holdings in RXO by 25.9% in the first quarter. PNC Financial Services Group Inc. now owns 6,797 shares of the company’s stock valued at $130,000 after purchasing an additional 1,398 shares during the last quarter. Invesco Ltd. grew its stake in RXO by 19.0% during the 1st quarter. Invesco Ltd. now owns 754,778 shares of the company’s stock valued at $14,416,000 after purchasing an additional 120,275 shares in the last quarter. Finally, Nuveen LLC purchased a new stake in RXO during the 1st quarter worth approximately $8,107,000. Institutional investors and hedge funds own 92.73% of the company’s stock.

Insider Activity

In related news, Director Thomas A. Szlosek acquired 20,308 shares of RXO stock in a transaction that occurred on Friday, November 7th. The stock was acquired at an average price of $12.37 per share, for a total transaction of $251,209.96. Following the transaction, the director directly owned 36,508 shares of the company’s stock, valued at $451,603.96. This trade represents a 125.36% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Andrew M. Wilkerson acquired 7,775 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were bought at an average price of $12.88 per share, with a total value of $100,142.00. Following the completion of the purchase, the chief executive officer owned 7,775 shares in the company, valued at $100,142. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders purchased 40,250 shares of company stock valued at $488,875. 2.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on RXO shares. Wall Street Zen cut RXO from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Truist Financial cut their price target on shares of RXO from $22.00 to $20.00 and set a “buy” rating on the stock in a report on Friday, November 7th. Benchmark reiterated a “hold” rating on shares of RXO in a research note on Wednesday, October 22nd. The Goldman Sachs Group decreased their price objective on shares of RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a report on Thursday, October 9th. Finally, UBS Group cut their target price on shares of RXO from $17.00 to $15.00 and set a “neutral” rating on the stock in a research note on Friday, November 7th. Four investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $16.69.

Read Our Latest Stock Report on RXO

RXO Stock Up 1.6%

RXO stock opened at $13.22 on Friday. The firm has a market cap of $2.17 billion, a price-to-earnings ratio of -30.74 and a beta of 1.67. Rxo Inc has a 1-year low of $10.43 and a 1-year high of $30.40. The firm has a fifty day moving average price of $15.21 and a two-hundred day moving average price of $15.78. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.32 and a quick ratio of 1.32.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). RXO had a negative net margin of 1.25% and a positive return on equity of 0.88%. The business had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same period in the prior year, the company earned $0.05 EPS. RXO’s quarterly revenue was up 34.6% on a year-over-year basis. Research analysts predict that Rxo Inc will post 0.31 EPS for the current year.

About RXO

(Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Recommended Stories

Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXOFree Report).

Institutional Ownership by Quarter for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.